https://asxan.ai/blog/nad-25-year-rct-history-evidence/ ASXAN · Evidence Long-Form Articles en 2026-05-26T00:00:00Z NAD+ 25-year RCT history: from Forsyth 1999 NADH to Zhang J 2025 meta NAD+, NMN, NR, NADH, niacin, longevity, mitochondrial, sirtuin, RCT chronology https://asxan.ai/blog/nmn-vs-nr-decision-tree-evidence/ ASXAN · Evidence Long-Form Articles en 2026-05-26T00:00:00Z NMN vs NR decision tree: 5-dimension head-to-head comparison NMN, NR, NAD+ precursor, decision tree, SLC12A8 https://asxan.ai/blog/reduced-nadh-vs-nmnh-evidence/ ASXAN · Evidence Long-Form Articles en 2026-05-26T00:00:00Z Reduced NADH vs NMNH: Tier B human RCT vs Tier C emerging NADH, NMNH, reduced NAD, redox form, CFS https://asxan.ai/blog/natural-vs-synthetic-astaxanthin-evidence-comparison/ ASXAN · Evidence Long-Form Articles en 2026-05-25T00:00:00Z Natural vs synthetic astaxanthin: evidence comparison astaxanthin, Haematococcus pluvialis, carotenoid, antioxidant, stereochemistry https://asxan.ai/blog/omega-3-evidence-history-cardiovascular-and-inflammation/ ASXAN · Evidence Long-Form Articles en 2026-05-25T00:00:00Z Omega-3 25-year RCT history: cardiovascular and EPA inflammation omega-3, EPA, DHA, cardiovascular, REDUCE-IT, GISSI, JELIS https://asxan.ai/blog/protein-source-decision-tree-whey-vs-yeast-focus/ ASXAN · Evidence Long-Form Articles en 2026-05-25T00:00:00Z Protein source decision tree: whey vs yeast focus protein, whey, casein, yeast, mycoprotein, DIAAS, GLP-1 https://asxan.ai/pt/blog/nad-25-year-rct-history-evidence/ ASXAN · Evidence Long-Form Articles (pt-BR) pt-BR 2026-05-29T00:00:00Z 25 Anos de Evidência Clínica NAD+ · De Niacina a NMN/NR/NADH NAD+, niacina, NR, NMN, NADH, longevidade, ANVISA RDC 243/2018, IN 28/2018 https://asxan.ai/pt/blog/nmn-vs-nr-decision-tree-evidence/ ASXAN · Evidence Long-Form Articles (pt-BR) pt-BR 2026-05-29T00:00:00Z NMN vs NR · Árvore de Decisão de Evidência NMN, NR, NAD+ precursor, árvore de decisão, ANVISA https://asxan.ai/pt/blog/reduced-nadh-vs-nmnh-evidence/ ASXAN · Evidence Long-Form Articles (pt-BR) pt-BR 2026-05-29T00:00:00Z NADH Reduzido vs NMNH · Forma Reduzida do Eixo NAD+ NADH, NMNH, Complexo I, Forsyth, Birkmayer, ANVISA https://asxan.ai/pt/blog/natural-vs-synthetic-astaxanthin-evidence-comparison/ ASXAN · Evidence Long-Form Articles (pt-BR) pt-BR 2026-05-29T00:00:00Z Astaxantina Natural vs Sintética · Comparação de Evidências Clínicas astaxantina, Haematococcus, estereoquímica, RDC 243/2018, IN 28/2018 https://asxan.ai/pt/blog/omega-3-evidence-history-cardiovascular-and-inflammation/ ASXAN · Evidence Long-Form Articles (pt-BR) pt-BR 2026-05-29T00:00:00Z Histórico de Evidência do Ômega-3 · Cardiovascular e Inflamação ômega-3, EPA, DHA, GISSI, REDUCE-IT, STRENGTH, DHA infantil ANVISA https://asxan.ai/pt/blog/protein-source-decision-tree-whey-vs-yeast-focus/ ASXAN · Evidence Long-Form Articles (pt-BR) pt-BR 2026-05-29T00:00:00Z Árvore de Decisão de Fonte de Proteína · Whey vs Levedura whey, proteína, DIAAS, GLP-1 companion, ANVISA muscular autorizada